Comparative Pharmacology
Head-to-head clinical analysis: PLASMA LYTE 56 AND DEXTROSE 5 IN PLASTIC CONTAINER versus PLASMA LYTE 56 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PLASMA LYTE 56 AND DEXTROSE 5 IN PLASTIC CONTAINER versus PLASMA LYTE 56 IN PLASTIC CONTAINER.
PLASMA-LYTE 56 AND DEXTROSE 5% IN PLASTIC CONTAINER vs PLASMA-LYTE 56 IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Plasma-Lyte 56 and Dextrose 5% is a crystalloid solution that provides electrolytes and carbohydrates. Dextrose is metabolized to glucose, which is utilized for cellular energy production. The electrolytes (sodium, chloride, potassium, magnesium, and acetate) maintain or restore intravascular volume, acid-base balance, and osmotic gradients. Acetate is metabolized to bicarbonate, providing an alkalinizing effect.
PLASMA-LYTE 56 is an isotonic crystalloid solution that provides electrolytes and water to maintain or restore intravascular volume and electrolyte balance. It expands extracellular fluid volume and improves circulation by increasing plasma volume. The solution's electrolyte composition mimics plasma, helping to correct electrolyte deficits and acid-base disturbances.
Intravenous infusion; dose depends on fluid and electrolyte requirements. Typical adult dose: 500-1000 mL as a single infusion, rate up to 333 mL/hour. Maximum 3 L/24 hours.
Intravenous infusion; dose depends on fluid and electrolyte needs; typical adult rate: 100-200 mL/hour.
None Documented
None Documented
Not applicable; composition-dependent. Dextrose half-life ~2 hours. Electrolytes follow endogenous regulation; no terminal elimination half-life defined.
Not applicable as a fixed value; infused electrolytes distribute and are eliminated according to individual ion kinetics (e.g., sodium t½ ~30 min, chloride t½ ~1–2 h) with rapid redistribution.
Renal 100% (electrolytes and dextrose metabolized to CO2 and water; excess water and electrolytes excreted unchanged in urine).
Primarily renal; >90% of infused electrolytes are excreted unchanged in urine; fecal elimination negligible (<5%).
Category C
Category C
Intravenous Electrolyte Solution
Intravenous Electrolyte Solution